Infectious Disease & Vaccines

The recent COVID-19 mRNA vaccines represent a new wave of vaccines based on mRNA technology.

Before its COVID-19 era hype, ivermectin was already a wonder drug for parasitic infections. Its renewed interest underscores the need for effective COVID-19 treatments and communication on proper research study design and analysis.

LIVE November 29th, 2021 at 11:00 AM ET
Investigating the pathophysiology and spread of human viruses

Increasing cAMP production blocks tuberculosis’ cholesterol metabolism, impairing its pathogenesis in mice.

Ultra-microscopic viruses that selectively target and kill bacteria may mitigate antimicrobial resistance.

Cardiologist Sheba Meymandi hopes to prevent the deadly cardiac effects of Chagas disease with increased screening and knowledge of the disease.

Scientists continue to ring alarm bells about the risks associated with the continued misuse of antimicrobials and advocate for innovative treatments, improved surveillance, and greater public health education.

A new delivery system initially developed to treat asthma sends corticosteroids deep into the lungs where COVID-19 infects cells, potentially slowing viral replication.

LIVE October 26th, 2021 at 11:00 AM ET
Experts will discuss recent advances in screening strategies to more efficiently identify therapeutic candidates for infectious diseases such as schistosomiasis and COVID-19.

A GLP-grade non-replicative Leishmania major parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.